MedTrace Logo

DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage

NCT05891509 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-09-13

No results posted yet for this study

Summary

Intracerebral hemorrhage (ICH) is a devastating disease with high early mortality, unfavorable neurological outcomes, and high cost of care. To date, the role of DTI-guided minimally invasive hematoma evacuation in ICH is still uncertain.

The investigators will conduct a multicenter randomized controlled trial, as well as a concurrent prospective observational study including all ICH patients who decline participation in the trial and will therefore receive minimally invasive hematoma evacuation or best medical therapy and consent to be followed up. All participants will be followed up at the same time using the same outcomes measures. The primary outcome will be collected by a blinded assessor.

Conditions

  • Stroke Hemorrhagic

Interventions

PROCEDURE

Minimally Invasive Hematoma Evacuation

Procedure of minimally invasive hematoma evacuation PLUS best medical therapy

OTHER

Best Medical Therapy

Best medical therapy

Sponsors & Collaborators

  • Xingguo County People's Hospital

    collaborator UNKNOWN

  • Zhongming Qiu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-03
Primary Completion
2027-05-31
Completion
2027-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05891509 on ClinicalTrials.gov